CY1124995T1 - Μεθοδοι για τη μειωση της εκπτωσης στη ζωτικη χωρητικοτητα - Google Patents

Μεθοδοι για τη μειωση της εκπτωσης στη ζωτικη χωρητικοτητα

Info

Publication number
CY1124995T1
CY1124995T1 CY20221100129T CY221100129T CY1124995T1 CY 1124995 T1 CY1124995 T1 CY 1124995T1 CY 20221100129 T CY20221100129 T CY 20221100129T CY 221100129 T CY221100129 T CY 221100129T CY 1124995 T1 CY1124995 T1 CY 1124995T1
Authority
CY
Cyprus
Prior art keywords
methods
reducing
discount
subject
capacity
Prior art date
Application number
CY20221100129T
Other languages
English (en)
Inventor
Jeremy M. SHEFNER
Andrew A. Wolff
Fady Malik
Jinsy A. ANDREWS
Original Assignee
Cytokinetics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytokinetics, Inc. filed Critical Cytokinetics, Inc.
Publication of CY1124995T1 publication Critical patent/CY1124995T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Εδώ παρέχονται συνθέσεις και μέθοδοι για τη μείωση της έκπτωσης στη ζωτική χωρητικότητα σε ένα άτομο με τη χορήγηση στο άτομο ενός ενεργοποιητή τροπονίνης σκελετικών μυών. Επίσης παρέχονται συνθέσεις και μέθοδοι για τη μείωση της αναπνευστικής έκπτωσης σε ένα άτομο, όπως μετρείται με αργή ζωτική χωρητικότητα (SVC), με χορήγηση στο άτομο ενός ενεργοποιητή τροπονίνης σκελετικών μυών.
CY20221100129T 2014-04-29 2022-02-15 Μεθοδοι για τη μειωση της εκπτωσης στη ζωτικη χωρητικοτητα CY1124995T1 (el)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461985799P 2014-04-29 2014-04-29
US201462006337P 2014-06-02 2014-06-02
US201462022407P 2014-07-09 2014-07-09
US201462094542P 2014-12-19 2014-12-19
PCT/US2015/027897 WO2015168064A1 (en) 2014-04-29 2015-04-28 Methods of reducing decline in vital capacity

Publications (1)

Publication Number Publication Date
CY1124995T1 true CY1124995T1 (el) 2023-01-05

Family

ID=54359220

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20221100129T CY1124995T1 (el) 2014-04-29 2022-02-15 Μεθοδοι για τη μειωση της εκπτωσης στη ζωτικη χωρητικοτητα

Country Status (13)

Country Link
US (1) US20170042890A1 (el)
EP (1) EP3137622B1 (el)
CY (1) CY1124995T1 (el)
DK (1) DK3137622T3 (el)
ES (1) ES2906218T3 (el)
HR (1) HRP20220183T1 (el)
HU (1) HUE057533T2 (el)
LT (1) LT3137622T (el)
PL (1) PL3137622T3 (el)
PT (1) PT3137622T (el)
RS (1) RS63018B1 (el)
SI (1) SI3137622T1 (el)
WO (1) WO2015168064A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8299248B2 (en) 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
IN2014DN00200A (el) 2011-07-13 2015-06-05 Cytokinetics Inc
TWI773118B (zh) 2016-02-12 2022-08-01 美商細胞動力學股份有限公司 四氫異喹啉衍生物
CN116635378A (zh) 2020-11-06 2023-08-22 赛特凯恩蒂克公司 二环1,4-二氮杂环庚酮和其治疗用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2017357A (en) * 1933-07-29 1935-10-15 Firm Soc Alsacienne De Const M Metal carriage for mule machines
US20100173930A1 (en) 2006-08-01 2010-07-08 Alex Muci Certain Chemical Entities, Compositions and Methods
US8227603B2 (en) * 2006-08-01 2012-07-24 Cytokinetics, Inc. Modulating skeletal muscle
ES2558517T3 (es) 2006-08-02 2016-02-04 Cytokinetics, Inc. Ciertas entidades químicas, composiciones y métodos que comprenden imidazopirimidinas
EP2139478A4 (en) 2007-03-30 2010-05-05 Cytokinetics Inc CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
US7998976B2 (en) 2008-02-04 2011-08-16 Cytokinetics, Inc. Certain chemical entities, compositions and methods
US7989469B2 (en) 2008-02-04 2011-08-02 Cytokinetics, Incorporated Certain chemical entities, compositions, and methods
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
IN2014DN00200A (el) * 2011-07-13 2015-06-05 Cytokinetics Inc
CN108553467A (zh) * 2012-04-02 2018-09-21 赛特凯恩蒂克公司 改善膈肌功能的方法
KR102163931B1 (ko) * 2012-04-11 2020-10-12 싸이토키네틱스, 인코포레이티드 골격근 피로에 대한 저항을 개선
DE102012103489B4 (de) * 2012-04-20 2015-11-12 Maschinenfabrik Reinhausen Gmbh Laststufenschalter und dessen Verwendung zur Spannungsregelung in einem Verteiltransformator

Also Published As

Publication number Publication date
ES2906218T3 (es) 2022-04-13
PL3137622T3 (pl) 2022-05-09
HRP20220183T1 (hr) 2022-04-29
RS63018B1 (sr) 2022-04-29
US20170042890A1 (en) 2017-02-16
WO2015168064A1 (en) 2015-11-05
SI3137622T1 (sl) 2022-05-31
EP3137622B1 (en) 2021-11-24
EP3137622A4 (en) 2018-01-10
LT3137622T (lt) 2022-04-25
EP3137622A1 (en) 2017-03-08
HUE057533T2 (hu) 2022-05-28
PT3137622T (pt) 2022-03-08
DK3137622T3 (da) 2022-02-07

Similar Documents

Publication Publication Date Title
CY1124995T1 (el) Μεθοδοι για τη μειωση της εκπτωσης στη ζωτικη χωρητικοτητα
CY1122308T1 (el) St2l ανταγωνιστες και μεθοδοι χρησης
CY1123853T1 (el) Ρυθμιστες nrf2
CY1121750T1 (el) Cot διαμορφωτες και μεθοδοι χρησης αυτων
CY1121225T1 (el) Συμπυκνωμενες iμιδαζολυλιμιδαζολες ως αντιiκες ενωσεις
CY1122329T1 (el) Anti-siglec-8 αντισωματα και μeθοδοι χρhσεως αυτων
CY1119110T1 (el) Ρυθμιστες ρ2χ7
CY1118680T1 (el) Φαρμακευτικη συνθεση
PH12016501151A1 (en) Nrf2 regulators
CR20160419A (es) Nuevos compuestos biciclicos
CY1121736T1 (el) Άλατα aramchol
CR20170100A (es) Indazoles sustituidos con bencilo como inhibidores bub1
TR201811764T4 (tr) Kinaz inhibitörleri olarak aminoheteroaril benzamidleri.
MX2017004838A (es) Composiciones de interleucina-15 y usos de estas.
EA201401077A1 (ru) Биспецифические антитела к человеческому tweak и человеческому il17 и их применения
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
CY1120759T1 (el) Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης
BR112017010177A2 (pt) composição para tratamento de tecido
CY1120481T1 (el) Kv1.3 ανταγωνιστες και μεθοδοι χρησης
CR20150440A (es) Nuevos derivados de piridina
UY36500A (es) Composiciones del inhibidor de la nitrificación y métodos de preparación de las mismas
CY1121238T1 (el) Παραγωγα παντοθενικου για την αντιμετωπιση νευρολογικων διαταραχων
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
CL2018001493A1 (es) Nuevos derivados de fenilo
CY1120906T1 (el) Συνθεσεις οξπρενολολης για τη θεραπεια του καρκινου